BioXcel Therapeutics, Inc.

NASDAQ:BTAI

0.3511 (USD) • At close December 24, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Omzet 0.2141.1040.5820.3760.3410.4570.2060.2380.1370000000000000000000000
Kosten van de omzet 1.170.0620.1580.7920.5120.0260.0090.0090.0110.0840.0770.0760.0760.080.0650014.7940000000000000
Brutowinst -0.9561.0420.424-0.416-0.1710.4310.1970.2290.126-0.084-0.077-0.076-0.076-0.08-0.06500-14.7940000000000000
Brutowinstmarge -4.4670.9440.729-1.106-0.5010.9430.9560.9620.920000001100000000000000
Onderzoek- en ontwikkelingskosten 5.1018.03211.1379.73119.61926.97327.832.45922.06217.90618.55912.52511.93313.50914.74111.40116.31717.90612.3716.4957.1226.5065.6746.0183.8211.7812.9381.4260.6190.3240.321
Algemene en administratieve kosten 09.14513.2649.28421.35521.06423.59520.66417.05418.38212.92113.60614.87911.1539.6439.6968.4513.5292.6251.9182.0122.1291.7451.2951.2981.4631.3481.10.2980.2410.208
Verkoop- en marketingkosten 00.305-0.0480.3192.9894.8082.59831.0432.7384.7190-4.94602.9511.9950000000000000000
Verkoop-, algemene en administratieve kosten 7.6839.4513.2169.58124.34425.87223.59520.66417.05418.38212.92113.60614.87914.10411.6389.6968.4513.5292.6251.9182.0122.1291.7451.2951.2981.4631.3481.10.2980.2410.208
Overige kosten 1.55300.0320.108-0.0050.537-0.246-0.480.0620000000000000000000000
Bedrijfskosten 14.33717.02324.35319.31243.96352.84551.39553.12339.11636.28831.4826.13126.81227.61326.37921.09724.76821.43514.9968.4139.1348.6357.4197.3135.1193.2444.2862.5260.9170.5650.529
Bedrijfsresultaat -15.293-16.058-23.929-19.728-48.297-52.414-51.198-52.894-38.99-36.288-31.48-26.131-26.812-27.613-26.379-21.097-24.768-21.435-14.996-8.413-9.134-8.635-7.419-7.313-5.119-3.244-4.286-2.526-0.917-0.565-0.529
Bedrijfsresultaat ratio -71.463-14.545-41.115-52.468-141.633-114.691-248.534-222.244-284.599000000-868,419,842.65-2,930,777,422.7900000000000000
Totaal overige inkomsten en kosten netto 1.6437.759-2.862-2.528-6.352-1.101-1.598-1.914-2.815-1.3820.0080.0060.001-0.0060.0030.0110.0150.0160.0850.1380.1160.1640.2150.2380.2320.2180.004-0.002000
Inkomen voor belasting -13.65-8.299-26.791-22.256-50.486-53.515-52.796-54.808-41.805-37.67-31.472-26.125-26.811-27.619-26.376-21.086-24.753-21.419-14.911-8.275-9.018-8.471-7.204-7.075-4.887-3.026-4.282-2.528-0.917-0.565-0.529
Inkomen voor belasting ratio -63.785-7.517-46.033-59.191-148.053-117.101-256.291-230.286-305.146000000-867,967,047.548-2,929,002,484.91300000000000000
Belastingkosten 000.035-5.2743.2473.796-1.7693.2772.8151.382-0.008106.8550.0120.010.01-0.0410.005-0.016-0.085-0.076-0.116-0.164-0.215-0.238-0.232-0.218-0000.0010
Nettowinst -13.65-8.299-26.791-22.256-50.486-53.515-51.027-58.085-44.62-39.052-31.464-26.125-26.811-27.619-26.376-21.086-24.753-21.419-14.911-8.275-9.018-8.471-7.204-7.075-4.887-3.026-4.282-2.528-0.917-0.565-0.529
Nettowinstmarge -63.785-7.517-46.033-59.191-148.053-117.101-247.704-244.055-325.693000000-867,967,047.548-2,929,002,484.91300000000000000
WPA (Winst Per Aandeel) -0.32-0.21-0.87-0.76-1.72-1.83-1.78-2.07-1.59-1.4-1.12-0.93-0.96-1.11-1.08-0.87-1.07-1.06-0.79-0.46-0.57-0.54-0.46-0.45-0.31-0.19-0.37-0.22-0.059-0.036-0.034
Verwaterde WPA -0.32-0.21-0.87-0.76-1.72-1.83-1.78-2.07-1.59-1.4-1.12-0.93-0.96-1.11-1.08-0.87-1.07-1.06-0.79-0.44-0.57-0.54-0.46-0.45-0.31-0.19-0.37-0.22-0.059-0.036-0.034
EBITDA -9.783-4.522-23.106-18.743-47.155-50.103-49.349-51.806-38.436-36-31.403-26.049-26.762-27.534-26.311-21.041-24.7-21.371-14.864-8.413-8.922-8.55-7.382-7.305-5.112-3.243-4.286-2.526-0.916-0.565-0.528
EBITDA ratio -45.715-4.096-40.981-52.261-126.076-109.792-239.947-218.013-284.599000000-868,419,842.65-2,925,097,621.58300000000000000